News Release

BAXTER TO EXPAND OFFERING OF PATIENT SAFETY TECHNOLOGIES WITH THE ACQUISITION OF AUTROS HEALTHCARE SOLUTIONS INC.

DEERFIELD, Ill. November 30, 2001 -- Baxter International Inc. announced today that a subsidiary has entered into a definitive agreement to acquire substantially all of the assets of AUTROS Healthcare Solutions Inc. AUTROS is a Canadian-based international leader of wireless, Internet-enabled patient information and medication management systems that improve patient safety by linking all health-care professionals involved in patient care with the decision-support needed to safely and correctly administer medication.

Upon closing, AUTROS Healthcare Solutions will become part of Baxter's Medication Delivery business that specializes in providing electronic infusion pumps and other devices used by health-care professionals to deliver intravenous medications. The incorporation of the AUTROS technology into the Baxter family of products will help to accelerate Baxter's vision of enhancing drug delivery systems that improve patient outcomes. "Using information systems as an integral component in the safe delivery of medication is becoming widely accepted among health-care providers worldwide," explains David F. Drohan, senior vice president and president of Baxter's Medication Delivery business. "The addition of the AUTROS System to our line of patient safety-focused infusion products will provide Baxter with the unmatched capability to address the important need to reduce medication errors through a comprehensive medication management system."

Using wireless hand-held computer devices, the AUTROS Point-of-Care Patient Management System links the physician, pharmacist and nurse in an interdisciplinary approach to patient care. The AUTROS System includes a computerized physician order-entry module, an inpatient pharmacy module, a wireless nurse charting system and an electronic patient medical record. Providing a comprehensive patient safety solution for the delivery of medication in a hospital environment, AUTROS' software modules seamlessly link to existing hospital systems using standard HL7 interfaces and can operate on a variety of computers and personal digital-assistant products to transmit orders and update patient medical records.

The report titled "To Err Is Human," published in November 1999 by the Institute of Medicine, cited that up to 7000 deaths each year are caused by medication errors. This led to increased awareness of the problem of patient safety in the U.S. health system. The acquisition of AUTROS will expand Baxter's offering of patient safety-focused products and provides Baxter with the opportunity to connect caregivers around the world with the real-time decision support they need to help ensure that the "five rights" of medication management -- right patient; right medication; right dose; right time and right route of administration -- is practiced when delivering both oral and intravenous medications, at the point of care to achieve the right patient outcome.

AUTROS Healthcare Solutions has received numerous awards and recognition for reducing the potential for medication errors and advancing patient safety. In 1999, AUTROS received the "Information Productivity" award for its installation at West Park Hospital in Toronto, the first testsite for the AUTROS system. In March 2001, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), selected Luther Midelfort-Mayo Health System for a live satellite videoconference entitled "Medication Error Reduction: Achieving Results" because of its outstanding policies and procedures aimed at reducing medication errors. Luther Midelfort-Mayo Health System is currently in the process of a live assessment of the AUTROS System. Luther Midelfort-Mayo is also a finalist for a grant to participate in Pursuing Perfection: Raising the Bar for Health Care Performance, an initiative being sponsored by the Robert Wood Johnson Foundation and the Institute for Healthcare Improvement to implement proven strategies or develop new approaches to defined health problems. Other AUTROS milestones include an exclusive partnership with the American Society of Health-System Pharmacists Foundation for the design of a fail-safe medication management system.

Both companies anticipate that the transaction will close in early January 2002, subject to regulatory and other approvals. The financial terms of the agreement will not be disclosed.

Baxter International Inc. (NYSE: BAX) is a global medical products and services company that, through its subsidiaries, provides critical therapies for people with life-threatening conditions. The company's products and services in bioscience (biopharmaceuticals, vaccines, biosurgery and transfusion therapies), medication delivery and renal therapy are used by health-care providers and their patients in more than 100 countries. Baxter's Medication Delivery business offers a single source for medication delivery products and services, including drug-delivery, intravenous solutions, sets, infusion pumps, parenteral nutrition products, anesthesia devices and pharmaceutical agents.

FOR ADDITIONAL INFORMATION:

	Media Contacts: George Rafeedie, Baxter, (847) 948-3675 Tova Manett, AUTROS, 1-800-537-2255 ext. 149 Investor Contacts: Neville Jeharajah, (847) 948-2875 Mary Kay Ladone, (847) 948-3371